Target Name: MIR1306
NCBI ID: G100302197
Other Name(s): hsa-miR-1306-3p | mir-1306 | MIRN1306 | hsa-mir-1306 | hsa-miR-1306-5p | MicroRNA 1306 | microRNA 1306

MIR1306: A Potential Drug Target and Biomarker

MIR1306 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play a critical role in various physiological processes in the body. One of the unique aspects of MIR1306 is its potential as a drug target and biomarker.

The discovery of MIR1306 as a potential drug target comes from a study by the research group of Dr. Qun Liu at the University of California, San Diego. This study identified MIR1306 as a protein that is expressed in the brain and is involved in the regulation of cell signaling pathways. The researchers found that MIR1306 was positively correlated with the level of a protein called PDGF-BB, which is a key signaling molecule involved in the development and maintenance of neural cells.

Further analysis of MIR1306 revealed that it was expressed in the brain and was highly expressed in the region of the brain that is responsible for sensory perception and movement. This suggests that MIR1306 may play a critical role in the regulation of neural function and could be a potential drug target for treating various neurological disorders.

As a biomarker, MIR1306 has been shown to be involved in the regulation of cell signaling pathways in various tissues. For example, a study by the research group of Dr. Liu at the University of California, San Diego found that MIR1306 was positively correlated with the level of a protein called NF-kappa-B, which is a signaling molecule that regulates inflammation and cellular processes.

Another study by the same research group found that MIR1306 was expressed in various tissues of the body, including the brain, heart, and kidneys, and was positively correlated with the level of a protein called COX, which is a signaling molecule involved in inflammation and pain.

The potential drug target status of MIR1306 is further supported by its expression in the brain, as it is well known that the brain is a difficult target for drugs. The fact that MIR1306 is expressed in the brain suggests that it may be possible to target it without causing unintended effects in other parts of the body.

In conclusion, MIR1306 is a protein that has the potential to be a drug target and biomarker. Its expression in various tissues of the body, including the brain, suggests that it plays a critical role in various physiological processes. Further studies are needed to determine its role in drug targeting and to develop biomarkers for its use.

Protein Name: MicroRNA 1306

More Common Targets

MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2